The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1669
February 6, 2023
View Complete Issue         Table of Contents 2019 
Epsolay - A Benzoyl Peroxide Cream for Rosacea
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Epsolay - A Benzoyl Peroxide Cream for Rosacea
February 6, 2023 (Issue: 1669)
Epsolay (Galderma), a 5% benzoyl peroxide cream, has been approved by the FDA for treatment of inflammatory lesions of rosacea in adults. It is the first product containing benzoyl peroxide to be approved in the US for treatment of rosacea....more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Epsolay - A Benzoyl Peroxide Cream for Rosacea
Article code: 1669c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.